EUVIMEDEUVIMED entdecken
Open Access

Secondary analysis reveals gut microbiota differences in patients with Parkinson’s disease and/or cognitive impairment

Xin Shen, Bing Leng, Shukun Zhang, Lai-Yu Kwok, Feiyan Zhao, Jia Zhao, Zhihong Sun, Jinbiao Zhang

Microbiome Research Reports · 28.08.2024 · 3 (4)

DOI: 10.20517/mrr.2024.35 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiome Research Reports, online erschienen am 28.08.2024. Verfasst von Xin Shen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Inner Mongolia Key Laboratory of Dairy Biotechnology and Engineering; Key Laboratory of Dairy Products Processing, Ministry of Agriculture and Rural …. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Parkinson’s disease (PD) is a neurodegenerative disorder, and the main clinical characteristics are bradykinesia and muscle stiffness. Cognitive impairment (CI) is a prevalent non-motor manifestation observed in individuals with PD. According to disease severity, it can be divided into PD with mild cognitive impairment (MCI) and PD dementia. CI in PD patients may precede motor symptoms, and the gut microbiota plays an important role in PD pathogenesis. Therefore, gut microbiota may be one of the diagnostic targets for PD-CI.

Methods

This study compared the gut microbiota of 43 PD-CI patients [Montreal Cognitive Assessment (MoCA) score < 26] and 38 PD patients without CI (MoCA ≥ 26). Patients’ neuropsychological conditions, depression scale, and brain structure scanned by magnetic resonance imaging (MRI) were also recorded. The fecal metagenomic datasets of patients with PD, PD-CI, and CI only were retrieved from public databases for reanalysis to explore the relationship between PD, CI, and gut microbiota.

Results

We found that the cortical thickness and the volume of the hippocampus, gray matter, and thalamus were significantly reduced among patients with PD-CI compared to PD without CI (P < 0.05). Moreover, the gut microbiome in patients with PD-CI had fewer short-chain fatty acid (SCFA) producing bacteria and more pathogenic bacteria. There were also alterations in patterns of metabolic pathway-encoding genes. Additionally, PD affected gut microbiota more than CI.

Conclusion

CI may aggravate the severity of PD, but it did not drastically alter subjects’ gut microbiota. This study reveals the relationship between gut microbiota, PD, and CI.

Schlagwörter

Stichwörter der Autor:innen

Parkinson’s diseasecognitive impairmentgut microbiotahippocampus

Autor:innen und Institutionen

  • Inner Mongolia Key Laboratory of Dairy Biotechnology and Engineering; Key Laboratory of Dairy Products Processing, Ministry of Agriculture and Rural Affairs; Key Laboratory of Dairy Biotechnology and Engineering, Minist…
  • Authors contributed equally.
  • Department of neurology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai 264200, Shandong, China.
  • Shandong Probincial Key Medical and Health Laboratory of Geriatric Gastrointestinal Tumor Pathology, Department of Pathology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai 264200, S…

Zitieren

APA

Shen, X., Leng, B., Zhang, S., Kwok, L. Y., Zhao, F., Zhao, J., Sun, Z., & Zhang, J. (2024). Secondary analysis reveals gut microbiota differences in patients with Parkinson’s disease and/or cognitive impairment. Microbiome Research Reports, 3(4). https://doi.org/10.20517/mrr.2024.35

Vancouver

Shen X, Leng B, Zhang S, Kwok LY, Zhao F, Zhao J, et al. Secondary analysis reveals gut microbiota differences in patients with Parkinson’s disease and/or cognitive impairment. Microbiome Research Reports. 2024;3(4). doi:10.20517/mrr.2024.35

BibTeX
@article{Shen2024,
  author = {Shen, Xin and Leng, Bing and Zhang, Shukun and Kwok, Lai-Yu and Zhao, Feiyan and Zhao, Jia and Sun, Zhihong and Zhang, Jinbiao},
  title = {Secondary analysis reveals gut microbiota differences in patients with Parkinson’s disease and/or cognitive impairment},
  journal = {Microbiome Research Reports},
  year = {2024},
  volume = {3},
  number = {4},
  doi = {10.20517/mrr.2024.35}
}
Kostenlos starten →